Abciximab (C7E3, 143653-53-6): A Research Reagent Overview Abciximab, also identified as C7E3 or bearing the CAS number 143653-53-6, represents a valuable laboratory compound extensively employed in cardiovascular research . This antibody fragment specifically targets the glycoprotein IIb/IIIa receptor on platelets , blocking platelet aggregation

Indusatumab GUCY2C: A Deep Dive into 1497400-26-6 Indusatumab GUCY2C, identified through the chemical reference 1497400-26-6, represents a novel antibody-drug compound currently in clinical assessment . This unique molecule unites an GUCY2C-specific monoclonal with a cytotoxic payload , designed to precisely block the GUCY2C receptor, which exhibi

Latikafusp represents a unique treatment approach for addressing particular malignancies, particularly instances involving fusion anaplastic lymphoma kinase proteins. This drug functions as an repressor of truncated ALK structures, demonstrating potential in research investigations and initial clinical assessments. Its mode of effect offers a speci